These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Monogenic epilepsies in humans: molecular mechanisms and relevance for the study of intractable epilepsy. Cossette P; Rouleau GA Adv Neurol; 2006; 97():381-8. PubMed ID: 16383149 [No Abstract] [Full Text] [Related]
24. [Primidone in the treatment of epilepsy; clinical evaluation]. MONTI AA; MOYANO JD Prensa Med Argent; 1956 Dec; 43(50):3691-5. PubMed ID: 13431664 [No Abstract] [Full Text] [Related]
25. Anticonvulsants; clinical considerations. YAHR MD Res Publ Assoc Res Nerv Ment Dis; 1959; 37():57-66; discussion 67-71. PubMed ID: 13646041 [No Abstract] [Full Text] [Related]
26. Mysoline: a clinical evaluation of a new drug in the treatment of refractory cases of epilepsy. SELBY G Med J Aust; 1953 Nov; 2(19):709-15. PubMed ID: 13119008 [No Abstract] [Full Text] [Related]
27. Considerations in the choice of an antiepileptic drug in the treatment of epilepsy. Azar NJ; Abou-Khalil BW Semin Neurol; 2008 Jul; 28(3):305-16. PubMed ID: 18777477 [TBL] [Abstract][Full Text] [Related]
28. New waves of research in the epilepsies: crossing into the third millennium. Delgado-Escueta AV; Wilson WA; Olsen RW; Porter RJ Adv Neurol; 1999; 79():3-58. PubMed ID: 10514804 [No Abstract] [Full Text] [Related]
29. [Etiopathogenesis, diagnosis and treatment of epilepsy]. Adam C Soins; 2007 Nov; (720):28-31. PubMed ID: 18376740 [No Abstract] [Full Text] [Related]
30. Clinical relevance of patients with epilepsy included in clinical trials. Tlusta E; Handoko KB; Majoie M; Egberts TC; Vlcek J; Heerdink ER Epilepsia; 2008 Aug; 49(8):1479-80. PubMed ID: 18754945 [No Abstract] [Full Text] [Related]
31. [The Andalusia Epilepsy Society's Guide to Epilepsy Therapy 2005: IV. General principles of antiepileptic polytherapy and therapeutic strategies in refractory epilepsy]. Sánchez-Alvarez JC; Altuzarra-Corral A; Mercadé-Cerdá JM; Casado-Chocán JL; Moreno-Alegre V; Rufo-Campos M; Camino-León R; Galán-Barranco JM; Pita-Calandre E; Ramos-Lizana J; Serrano-Castro PJ; Rev Neurol; 2005 Jun 16-30; 40(12):743-50. PubMed ID: 15973642 [TBL] [Abstract][Full Text] [Related]
32. Clinical evidence that epilepsy is a progressive disorder with special emphasis on epilepsy syndromes that do progress. Holmes GL Adv Neurol; 2006; 97():323-31. PubMed ID: 16383141 [No Abstract] [Full Text] [Related]
33. Investigations: how the data affect management. Blume WT; Lee DH Adv Neurol; 2006; 97():517-26. PubMed ID: 16383159 [No Abstract] [Full Text] [Related]
35. Evidence in support of treating interictal epileptiform discharges in cerebral palsy patients without clinical epilepsy for an improved prognostic outcome and quality of life. Jaseja H Clin Neurol Neurosurg; 2009 May; 111(4):396-7. PubMed ID: 19110373 [No Abstract] [Full Text] [Related]
37. About systematic reviews and the treatment gap in epilepsy. Burneo JG Epilepsia; 2009 May; 50(5):1293-4. PubMed ID: 19496811 [No Abstract] [Full Text] [Related]
38. Seizure disorders and epilepsy. Ozuna J Lippincotts Prim Care Pract; 2000; 4(6):608-18. PubMed ID: 11933374 [TBL] [Abstract][Full Text] [Related]